What are psychedelics?

​

The term "psychedelic" refers to the mind-manifesting properties of certain substances, as it comes from the Greek words "psyche" (mind) and "delein" (to manifest). These include substances like psilocybin (magic mushrooms), and MDMA. These compounds can lead to profound and altered states of consciousness, making them subjects of interest for therapeutic and spiritual exploration. It's essential to use them responsibly, as they can have both beneficial and challenging effects on individuals. Always adhere to local laws and regulations regarding their use.

​

​

Why are psychedelics used for therapy?

​

Much research suggests that psychedelics may have therapeutic potential for conditions like depression, PTSD, CPTSD, and anxiety. This is a rapidly evolving field of study, and more research emerges daily. Institutions conducting active research include: Johns Hopkins University, Kings College in London, Columbia University of New York among several others. 

​

​

What does psychedelic integration involve?

​

Psychedelic integration refers to the processing and incorporating of insights, emotions, and experiences that emerge from a psychedelic journey into everyday life. Integration involves discussing these insights, and experiences with a qualified person, who provides a supportive and non-judgmental space to explore their significance, as well as helping you map out their implications on personal growth and the healing of past wounds. This process is crucial for capturing the therapeutic benefits of a psychedelic experience, and ensuring a lasting change.

​

​

What is the difference between psilocybin and MDMA

for therapy?

​

Psilocybin, naturally occurring in "magic mushrooms," is a hallucinogenic compound. It tends to promote introspection and profound changes in perception and thought patterns, which may facilitate therapeutic insights. Phase 3 clinical studies for the use of Psilocybin in treating depression have been launched. Psilocybin is a teacher offering wisdom.

MDMA, is a non-hallucinogenic empathogen. Empathogens are a class of psychoactive drugs that produce experiences of emotional communion, oneness, relatedness. MDMA promotes feelings of trust, empathy, and well-being, which help individuals process traumatic memories in the context of therapy. Phase 3 clinical trials have been highly successful in showing MDMA's efficacy in treating PTSD. MDMA returns you back to your own wisdom.

 

​

What are 'set' and 'setting'?

​

'Set' and 'setting' are terms used in the context of psychedelic experiences. 'Set' refers to the individual's mindset or psychological state before and during the psychedelic experience, including their expectations, mood, and general outlook. Your intention is part of your 'Set'.

'Setting' refers to the physical and social environment where the psychedelic experience takes place. Both 'set' and 'setting' can significantly influence the nature of a psychedelic experience, which is why it's important to ensure a safe and supportive setting and a mind set for therapeutic benefit.

 

​

How do I best choose an intention for a journey?

​

Setting an intention for a psychedelic journey is a deeply personal process, and a really important step in the healing you hope to achieve. It's helpful to spend some time in reflection or discussion with a knowledgable person you trust, to identify the most meaningful and relevant intention. This is where a lot of work is set in motion, so if possible, spend up to a week holding your intention before you proceed with a journey. The very process of noticing how the intention can shift from a mantra, to a goal, or journaling how it makes you feel, becomes a big part of the healing journey, even in the absence of any substances. Remember, the intention isn't a goal to be achieved; instead, it's more of a preparation for your journey, and the peculiar thing is that it may shift, and that is also ok.

 

​

What can I expect the day after journeying with MDMA?

​

The day after an MDMA therapy session is often referred to as a "comedown" or "afterglow" period. The nature of this period can vary widely among individuals. Some people might experience a sense of peace, clarity, and emotional openness, while others might feel physical or emotional exhaustion, anxiety, or depression. It's important to plan for rest and support during this time. Hydrating, eating nutritious food, resting, gentle exercise, and talking through your feelings with a trusted and knowledgable person can be helpful.

​

​

Are psychedelics safe?

​

The safety of psychedelics depends on a variety of factors including the specific substance, dosage, set and setting, and the individual's mental and physical health. While many people use psychedelics without harm, it is important to proceed with caution, consult with your doctor, and abide by your local laws.

​

As reported in The Economist: "In 2010 a group of British drug experts ranked 20 popular intoxicating substances on 16 physical, psychological and social harms, including those done to non-users, such as crime and family breakdown. Alcohol came out as the most harmful, followed by heroin and crack cocaine. Psychedelic “party” drugs, including ecstasy, LSD and mushrooms, were deemed mostly benign—with harm scores less than half that of tobacco."

​

​

Are you a licensed therapist?

​

Although I am not a licensed therapist, I offer a uniquely direct and empathetic perspective in guiding the integration of psychedelic journeys. My deep understanding of psychedelics coupled with a personal history of trauma, help me create a strong and nurturing connection with my clients. Rather than following traditional therapeutic models, I adopt a more personalized and holistic approach. As a researcher, with two graduate degrees in the field of humanities, I continue to dedicate significant time and resources to learning about the available therapeutic modalities. Ones that seem to inform my framework most are Attachment Theory, Internal Family Systems, and Somatic Experiencing. I am committed to understanding and respecting the effects and potential risks associated with psychedelic substances, as well as promoting safe practices.

​

​